Patheon Places Big Bet with Mova Acquisition

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-02-2005, Volume 29, Issue 1

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-01-02-2005
N4 Pharma and SRI to Collaborate on Intracellular Delivery to Specific Target Cells
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
Annex 1 Alignment: Addressing Contamination Control and Assessing Risk